Udi number for this product code is not required.The actual device was not returned to the manufacturing facility for evaluation.Therefore, the investigation was based on the evaluation of user facility information and evaluation of a retention sample from the reported product code/lot number combination.Visual inspection revealed no anomalies or defects.The sample was built into a circuit with tubes.Bovine blood was circulated in the circuit, while the pressure drop was determined at each flow rate.The obtained values were confirmed to meet manufacturer specifications.Bovine blood was then circulated for six hours.No obstruction occurred.When the circulation was ceased, the actual sample was flushed with water.No clot was revealed which could have lead to an increase in the pressure.A review of the device history record and product release decision control sheet of the involved product code/lot number combination revealed no relevant findings.A search of the complaint file found no previous report of this nature with the involved product code/lot number combination.There is no evidence this event was related to a device defect or malfunction.The investigation results verified the retention sample was the normal product without any deficiency which could have been a trigger of the reported increase in the pressure drop.The exact cause of the reported event cannot be definitively determined based on the available information.The device labeling does address the potential for such an event in the instructions-for-use (ifu) with statements such as the following: do not reduce heparin during circulation.Otherwise, blood clotting might occur.Adequate heparinization of the blood is required to prevent it from clotting in the system.(b)(4).
|